1文献来源Pedersen KM,Zangger G,Brochmann N,et al.The effectiveness of exercise-based rehabilitation to patients with myeloproliferative neoplasms-An explorative study[J]. Eur J Cancer Care (Engl),2018,27(5):e12865.
1文献来源Rollig C,Serve H,Hüttmann A,et al.Addition of Sorafenib versus placebo to standard therapy in patients aged60 years or younger with newly diagnosed acute myeloidleukaemia(SORAML):A multicentre,phase 2...1文献来源Rollig C,Serve H,Hüttmann A,et al.Addition of Sorafenib versus placebo to standard therapy in patients aged60 years or younger with newly diagnosed acute myeloidleukaemia(SORAML):A multicentre,phase 2,randomised controlled tria[lJ].Lancet Oncol,2015,16(16):1691-1699.2证据水平1b。3背景·目前急性髓系白血病(acute myeloidleukemia,AML)的标准治疗方案是阿糖胞苷联合葸环类或者蒽醌类药物,展开更多
文摘1文献来源Pedersen KM,Zangger G,Brochmann N,et al.The effectiveness of exercise-based rehabilitation to patients with myeloproliferative neoplasms-An explorative study[J]. Eur J Cancer Care (Engl),2018,27(5):e12865.
文摘1文献来源Rollig C,Serve H,Hüttmann A,et al.Addition of Sorafenib versus placebo to standard therapy in patients aged60 years or younger with newly diagnosed acute myeloidleukaemia(SORAML):A multicentre,phase 2,randomised controlled tria[lJ].Lancet Oncol,2015,16(16):1691-1699.2证据水平1b。3背景·目前急性髓系白血病(acute myeloidleukemia,AML)的标准治疗方案是阿糖胞苷联合葸环类或者蒽醌类药物,